Reshoring US Pharmaceutical Production Would Create 800K Jobs

Health, Security, Economic Benefits from Reshoring By Steven L. Byers, PhD and Jeff Ferry With the spreading coronavirus pandemic, Americans are becoming increasingly aware of our dependence on foreign sources for important pharmaceuticals and other health care products. The US is dependent on China for over one third of all the antibiotics we import, and…

Op-ed | It’s Time To Rebuild Domestic Drug Production in the US, for Both Health and Economic Reasons

Editor’s Note: Jeff Ferry is chief economist at the Coalition for a Prosperous America (CPA). Two decades of offshoring pharmaceuticals has hurt our national security. [Jeff Ferry | March 17, 2020 | Industry Week] With breathtaking speed, the coronavirus has revealed a previously overlooked vulnerability in the U.S. economy. The United States has become heavily dependent…